Braun Stacey Associates Inc. Boosts Stock Position in Colgate-Palmolive Company $CL

Braun Stacey Associates Inc. lifted its stake in Colgate-Palmolive Company (NYSE:CL) by 5.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 235,865 shares of the company’s stock after purchasing an additional 12,075 shares during the quarter. Braun Stacey Associates Inc.’s holdings in Colgate-Palmolive were worth $20,103,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Teacher Retirement System of Texas increased its holdings in shares of Colgate-Palmolive by 35.3% during the 4th quarter. Teacher Retirement System of Texas now owns 469,624 shares of the company’s stock worth $37,110,000 after buying an additional 122,634 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Colgate-Palmolive by 114.2% in the fourth quarter. GAMMA Investing LLC now owns 23,329 shares of the company’s stock valued at $1,843,000 after acquiring an additional 12,437 shares during the last quarter. Grantham Mayo Van Otterloo & Co. LLC grew its position in Colgate-Palmolive by 217.0% in the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 40,605 shares of the company’s stock worth $3,246,000 after acquiring an additional 27,796 shares during the period. Avior Wealth Management LLC acquired a new stake in Colgate-Palmolive during the fourth quarter worth $1,135,000. Finally, Flputnam Investment Management Co. increased its stake in Colgate-Palmolive by 7.4% during the fourth quarter. Flputnam Investment Management Co. now owns 200,972 shares of the company’s stock worth $15,881,000 after acquiring an additional 13,804 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.1%

CL opened at $92.06 on Friday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. The business has a fifty day simple moving average of $88.07 and a 200-day simple moving average of $87.04. The firm has a market cap of $73.66 billion, a P/E ratio of 35.82, a P/E/G ratio of 4.85 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The company’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 EPS. On average, equities analysts expect that Colgate-Palmolive Company will post 3.81 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 82.49%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Sanford C. Bernstein assumed coverage on Colgate-Palmolive in a research note on Thursday, June 11th. They issued a “market perform” rating and a $96.00 price target on the stock. Rothschild & Co Redburn set a $100.00 price objective on shares of Colgate-Palmolive and gave the company a “buy” rating in a report on Tuesday, April 21st. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Colgate-Palmolive in a research note on Friday, May 1st. TD Cowen reiterated a “hold” rating and set a $85.00 price target on shares of Colgate-Palmolive in a research report on Tuesday, March 31st. Finally, JPMorgan Chase & Co. lifted their price target on shares of Colgate-Palmolive from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Monday, May 4th. Twelve equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.